Plasma urotensin-2 level and Thr21Met but not Ser89Asn polymorphisms of the urotensin-2 gene are associated with migraines
Open Access
- 18 April 2016
- journal article
- research article
- Published by Springer Nature in The Journal of Headache and Pain
- Vol. 17 (1) , 36
Abstract
Urotensin-II (U-II) is a peptide recognized by its potent vasoconstrictor activity in many vascular events, however the role of urotensin-II in migraine has not been considered yet. The molecular mechanisms and genetics of migraine have not been fully clarified yet, but it is well-known that vascular changes considerably contribute in pathophysiology of migraine and also its complications. The aim of this study was to analyze the plasma U-II levels along with genotype distributions and allele frequencies for UTS2 Thr21Met and Ser89Asn polymorphisms among the patients with migraine without aura (MWoA). One hundred eighty-six patients with MWoA and 171 healthy individuals were included in this study. Plasma U-II levels were measured in attack free period. The genotype and allele frequencies for the Thr21Met (T21M) and Ser89Asn (S89N) polymorphisms in the UTS2 gene were analyzed. Plasma U-II levels were significantly higher in MWoA patients (p = 0.002). We detected a significant association between the T21M polymorphism in the UTS2 gene and migraine (53.8 % in patients, 40.4 % in controls, p = 0.035), but not with S89N polymorphism (p = 0.620). A significant relationship was found between U-II levels and MIDAS score (β = 0.508, p = 0.001). Our study suggests that U-II may play a role in migraine pathogenesis; also Thr21Met polymorphism was associated with the risk of migraine disease. Further studies are needed for considering the role of U-II in migraine pathophysiology and for deciding if UTS2 gene may be a novel candidate gene in migraine cases.Keywords
This publication has 39 references indexed in Scilit:
- Genetics of migraine in the age of genome-wide association studiesThe Journal of Headache and Pain, 2011
- Urotensin II, from fish to humanAnnals of the New York Academy of Sciences, 2010
- Performance of the Cockcroft-Gault, MDRD, and New CKD-EPI Formulas in Relation to GFR, Age, and Body SizeClinical Journal of the American Society of Nephrology, 2010
- Pathophysiology of MigraineSeminars in Neurology, 2010
- Migraine as a Systemic VasculopathyCephalalgia, 2009
- Neuropeptide interactions and REM sleep: A role for Urotensin II?Peptides, 2008
- Behavioral actions of urotensin-IIPeptides, 2008
- Localization of the urotensin II receptor in the rat central nervous systemJournal of Comparative Neurology, 2006
- The international classification of headache disorders, 2nd edn (ICDH-II)Journal of Neurology, Neurosurgery & Psychiatry, 2004
- From ‘gills to pills’: urotensin-II as a regulator of mammalian cardiorenal functionTrends in Pharmacological Sciences, 2004